Knoll Capital Management LLC 13D and 13G filings for Corbus Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-16 10:45 am Purchase |
2023-12-26 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Knoll Capital Management LLC | 3,881,879 9.967% |
3,799,070 (+4587.74%) |
Filing |
| 2021-06-14 12:58 pm Purchase |
2021-05-19 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Knoll Capital Management LLC | 82,809 10.400% |
24,764 (+42.66%) |
Filing |
| 2021-02-16 2:48 pm Purchase |
2020-12-31 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Knoll Capital Management LLC | 58,045 8.300% |
58,045 (New Position) |
Filing |
| 2020-08-14 4:13 pm Purchase |
2020-04-23 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Knoll Capital Management LLC | 43,879 5.900% |
43,879 (New Position) |
Filing |